Literature DB >> 1693942

Interferon induction by human herpesvirus 6 in human mononuclear cells.

H Kikuta1, A Nakane, H Lu, Y Taguchi, T Minagawa, S Matsumoto.   

Abstract

Interferon (IFN) production after inoculation with human herpesvirus 6 (HHV-6) was studied in peripheral blood mononuclear cells from 10 HHV-6-seropositive healthy adults and five samples of cord blood mononuclear cells. When the cells were exposed to HHV-6 at a multiplicity of infection of 10(-2) 50% tissue culture infectious doses/cell, IFN activity was detected as early as 12 h after exposure to HHV-6, plateaued at days 2-5, and gradually decreased thereafter. IFN was also induced by ultraviolet-inactivated but not heat-inactivated HHV-6. The response of cord blood mononuclear cells was lower than that of the cells from healthy adults. The activity of all IFN samples was stable to acid and exclusively neutralized by anti-human IFN-alpha. The IFN-producing cell population was mainly non-T cells and monocytes. Furthermore, exogenous IFN suppressed HHV-6 replication. Production of IFN-alpha may be an important part of the host response to HHV-6.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693942     DOI: 10.1093/infdis/162.1.35

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Potential screening assay for undetectable viruses on the basis of their capacity to induce alpha interferon production.

Authors:  Barbara Schmidt; Brittany Ashlock; Frank Neipel; Jay A Levy
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

3.  A study of childhood febrile convulsions with particular reference to HHV-6 infection: pathogenic considerations.

Authors:  M F Bertolani; M Portolani; F Marotti; A M Sabbattini; C Chiossi; M R Bandieri; G B Cavazzuti
Journal:  Childs Nerv Syst       Date:  1996-09       Impact factor: 1.475

4.  Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases.

Authors:  M Luppi; P Barozzi; R Garber; A Maiorana; G Bonacorsi; T Artusi; R Trovato; R Marasca; G Torelli
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 5.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  Divergent susceptibilities of human herpesvirus 6 variants to type I interferons.

Authors:  Joanna Jaworska; Annie Gravel; Louis Flamand
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

7.  Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9.

Authors:  Joséphine M Reynaud; Jean-François Jégou; Jérémy C Welsch; Branka Horvat
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

8.  Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures.

Authors:  L Flamand; J Gosselin; M D'Addario; J Hiscott; D V Ablashi; R C Gallo; J Menezes
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

9.  The U95 protein of human herpesvirus 6B interacts with human GRIM-19: silencing of U95 expression reduces viral load and abrogates loss of mitochondrial membrane potential.

Authors:  W M Yeo; Yuji Isegawa; Vincent T K Chow
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

10.  Establishment and functional characterization of human herpesvirus 6-specific CD4+ human T-cell clones.

Authors:  Y Yakushijin; M Yasukawa; Y Kobayashi
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.